Citation Impact
Citing Papers
Cardiac Hypertrophy: The Good, the Bad, and the Ugly
2003 Standout
Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition
2022 StandoutNobel
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions
2007 Standout
Differential Distribution of Angiotensin AT2 Receptors in the Normal and Failing Human Heart
1998
Angiotensin II receptor antagonists in heart failure: Rationale and design of the evaluation of losartan in the elderly (ELITE) trial
1995
Independent β-Arrestin2 and Gq/Protein Kinase Cζ Pathways for ERK Stimulated by Angiotensin Type 1A Receptors in Vascular Smooth Muscle Cells Converge on Transactivation of the Epidermal Growth Factor Receptor
2009 StandoutNobel
Downregulation of angiotensin converting enzyme II is associated with pacing‐induced sustained atrial fibrillation
2007
Cellular and molecular mechanisms of fibrosis
2007 Standout
Angiotensin II Controls p21 Activity via pp60
1996
Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.
1997
Multistage Nanoparticles for Improved Delivery into Tumor Tissue
2012 StandoutNobel
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
β-Arrestin 1 and Gαq/11 Coordinately Activate RhoA and Stress Fiber Formation following Receptor Stimulation
2004 StandoutNobel
The pathogenesis of cardiac fibrosis
2013 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
G Protein-coupled Receptors Mediate Two Functionally Distinct Pathways of Tyrosine Phosphorylation in Rat 1a Fibroblasts
1997 StandoutNobel
Role of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and disease
1999
Infarct scar: a dynamic tissue
2000
Over-expression of angiotensin converting enzyme-1 augments cardiac hypertrophy in transgenic rats
2004
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Animal Models of Heart Failure Recent Developments and Perspectives
1997
The inflammatory response in myocardial infarction
2002 Standout
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
2007 Standout
Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction
1994
β-Arrestin1 Interacts with the Catalytic Domain of the Tyrosine Kinase c-SRC
2000 StandoutNobel
Pathophysiological regulation of the AT1-receptor and implications for vascular disease
2006
Fluorescent Nanorods and Nanospheres for Real‐Time In Vivo Probing of Nanoparticle Shape‐Dependent Tumor Penetration
2011 StandoutNobel
Healing after myocardial infarction
2005
Mitogenic Signaling via G Protein-Coupled Receptors
1996 StandoutNobel
Cultured neonatal rat cardiac myocytes and fibroblasts do not synthesize renin or angiotensinogen evidence for stretch-induced cardiomyocyte hypertrophy independent of angiotensin II
1999
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
1997 Standout
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.
1998 Standout
The inflammatory response in myocardial injury, repair, and remodelling
2014 Standout
Chronic AT1 receptor blockade and angiotensin-converting enzyme (ACE) inhibition in (CHF 146) cardiomyopathic hamsters: effects on cardiac hypertrophy and survival
1999
Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function
2001 Standout
Significance of angiotensin I-converting enzyme and angiotensin II type 1 receptor gene polymorphisms as risk factors for coronary heart disease
1996
Investigational drugs targeting cardiac fibrosis
2013
Cardiovascular Effects of Aldosterone and Post–Acute Myocardial Infarction Pathophysiology
2006
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
2006 Standout
The renin–angiotensin system and experimental heart failure
1999
Organic Azides: An Exploding Diversity of a Unique Class of Compounds
2005 Standout
Effect of ramipril and losartan on collagen expression in right and left heart after myocardial infarction
1996
Gβγ Subunits Mediate Src-dependent Phosphorylation of the Epidermal Growth Factor Receptor
1997 StandoutNobel
Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction.
1996
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
2007 Standout
TGF-?1 and angiotensin networking in cardiac remodeling
2004
Dosage‐dependent switch from G protein‐coupled to G protein‐independent signaling by a GPCR
2006 StandoutNobel
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
Blood Pressures and Cardiovascular Homeostasis in Mice Having Reduced or Absent Angiotensin-Converting Enzyme Gene Function
1997 StandoutNobel
Angiotensin AT 1 Receptor Inhibition
1997
A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9
2000 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Angiotensin II Has Multiple Profibrotic Effects in Human Cardiac Fibroblasts
2000
Hydrolysis by Cathepsin B of Fluorescent Peptides Derived From Human Prorenin
2000 StandoutNobel
Segregation and linkage analysis of serum angiotensin I-converting enzyme levels: evidence for two quantitative-trait loci.
1995 StandoutNobel
Chronic Angiotensin-Converting Enzyme Inhibition and Angiotensin II Type 1 Receptor Blockade
1997
Activation of Cardiac Aldosterone Production in Rat Myocardial Infarction
1999
Tissue-Specific Expression of a Rat Renin Transcript Lacking the Coding Sequence for the Prefragment and Its Stimulation by Myocardial Infarction*
2000
Functional Consequences of Altering Myocardial Adrenergic Receptor Signaling
2000 StandoutNobel
Bradykinin Antagonism Inhibits the Antigrowth Effect of Converting Enzyme Inhibition in the Dog Myocardium After Discrete Transmural Myocardial Necrosis
1995
Extracellular Matrix Remodeling in Heart Failure
1997
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
2000 Standout
Fluorescent Nanorods and Nanospheres for Real‐Time In Vivo Probing of Nanoparticle Shape‐Dependent Tumor Penetration
2011 StandoutNobel
Effects of Candesartan and Cilazapril on Rats With Myocardial Infarction Assessed by Echocardiography
1999
Myocardial infarction and remodeling in mice: effect of reperfusion
1999
Losartan: a selective angiotensin II type 1 (AT1) receptor antagonist for the treatment of heart failure
1998
CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASES
1997 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
G PROTEIN–COUPLED RECEPTOR KINASES
1998 StandoutNobel
Pathophysiological Role of Angiotensin II Type 2 Receptor in Cardiovascular and Renal Diseases
1998
Characteristics of 9194 Patients With Left Ventricular Hypertrophy
1998
Renin-Angiotensin System Components in the Interstitial Fluid of the Isolated Perfused Rat Heart
1997
Angiotensin-Converting Enzyme Gene Mutations, Blood Pressures, and Cardiovascular Homeostasis
1997 StandoutNobel
Molecular Mechanisms of Myocardial Remodeling
1999 Standout
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
2000
Mechanisms of Renal Fibrosis
2017 Standout
p38 MAP Kinase Regulates Vascular Smooth Muscle Cell Collagen Synthesis by Angiotensin II in SHR But Not in WKY
2001
Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
2011
Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure
2000 Standout
Expression of G qα and PLC-β in Scar and Border Tissue in Heart Failure Due to Myocardial Infarction
1998
Matrix Metalloproteinase Inhibition Attenuates Early Left Ventricular Enlargement After Experimental Myocardial Infarction in Mice
1999
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002 Standout
Works of S. Seitz being referenced
Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
1994